Media coverage
1Media coverage
Title VeroScience Continues To Explore Clinical Benefits Of Circadian Neuroendocrine Resetting Therapy With Six Papers Presented At 2016 American Diabetes Association Scientific Sessions June 10-14 Media name/outlet BioSpace Country United States Date 6/13/16 Persons Ralph A Defronzo